1. Home
  2. ARTV vs MPU Comparison

ARTV vs MPU Comparison

Compare ARTV & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • MPU
  • Stock Information
  • Founded
  • ARTV 2019
  • MPU 1989
  • Country
  • ARTV United States
  • MPU Singapore
  • Employees
  • ARTV N/A
  • MPU N/A
  • Industry
  • ARTV
  • MPU Transportation Services
  • Sector
  • ARTV
  • MPU Consumer Discretionary
  • Exchange
  • ARTV NYSE
  • MPU Nasdaq
  • Market Cap
  • ARTV 39.0M
  • MPU 35.5M
  • IPO Year
  • ARTV 2024
  • MPU 1998
  • Fundamental
  • Price
  • ARTV $1.61
  • MPU $1.63
  • Analyst Decision
  • ARTV Strong Buy
  • MPU
  • Analyst Count
  • ARTV 8
  • MPU 0
  • Target Price
  • ARTV $18.14
  • MPU N/A
  • AVG Volume (30 Days)
  • ARTV 303.9K
  • MPU 673.0K
  • Earning Date
  • ARTV 08-28-2025
  • MPU 08-13-2025
  • Dividend Yield
  • ARTV N/A
  • MPU N/A
  • EPS Growth
  • ARTV N/A
  • MPU N/A
  • EPS
  • ARTV N/A
  • MPU N/A
  • Revenue
  • ARTV N/A
  • MPU $35,228,600.00
  • Revenue This Year
  • ARTV N/A
  • MPU N/A
  • Revenue Next Year
  • ARTV N/A
  • MPU N/A
  • P/E Ratio
  • ARTV N/A
  • MPU N/A
  • Revenue Growth
  • ARTV N/A
  • MPU 305.32
  • 52 Week Low
  • ARTV $1.47
  • MPU $0.49
  • 52 Week High
  • ARTV $17.31
  • MPU $1.98
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • MPU 77.55
  • Support Level
  • ARTV N/A
  • MPU $0.80
  • Resistance Level
  • ARTV N/A
  • MPU $1.70
  • Average True Range (ATR)
  • ARTV 0.00
  • MPU 0.19
  • MACD
  • ARTV 0.00
  • MPU 0.08
  • Stochastic Oscillator
  • ARTV 0.00
  • MPU 89.22

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About MPU Mega Matrix Corp.

Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: